Therefore, ACSL4, SLC7A11, and GPX4 are key links necessary links in the synergistic effect between these two, providing an experimental basis for HNSCC treatment with ferroptosis inducers and PLK1 inhibitors. This evidence concerns the gene SLC7A11 and head and neck squamous cell carcinoma.